Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Activities

Taller de preparació de propostes Horizon Europe - Clúster Salut i Missió Càncer

10.15h Benvinguda 10.30h Presentació del Programa de Treball Clúster Salut + Missió Càncer i aspectes pràctics de la proposta.  Marta Marín, FECYT i Marta de Diego, CDTI 11.15h Casos d'èxit:  -Clúster Salut: Trustroke (HORITZÓ-HLTH-2022-STA

News

Vall d’Hebron unveils the first model capable of predicting the long-term progression of multiple sclerosis from the first episode

The Barcelona Risk Score is a flexible, generalisable clinical tool that will play a key role in selecting the most effective treatment for each person with multiple sclerosis

News

A study led by Vall d'Hebron analyzes the largest European registry on COVID-19 in patients with rare blood diseases

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

News

VHIR is the first research center in Catalonia to obtain ISO 56001:2024 innovation management certification

This certification pushes our system towards a more mature model, with defined processes, clear metrics and a real focus on impact.

Activities

Vall d'Hebron Talks by VHIR 'L'ús de la realitat virtual per a la millora de l'atenció emocional del pacient pediàtric'

Ponent: Clàudia Serra i Masmitjà, Infermera del programa Atenció alumnat amb necessitats de salut als Centres d'Educació Especial. Hospital Infantil i de la Dona - Hospital Universitari Vall d’Hebron. Resum: L’ús de la realitat virtual (RV) com a intervenció no farmacològica per a

News

Dr. Ariadna Laguna, finalist at La Vanguardia de la Ciència Awards

The nomination recognises the work she has led together with Dr. Núria Peñuelas and Dr. Miquel Vila, on the generation of new preclinical models to study Parkinson's disease.

Activities

Sessions de Medicina Interna

Curs 2024-2025 Accessibilitat presencial Sala d'actes planta 0-Hospital General Coordinadors: M. Salcedo. M. Ventura. A. Guillén

News

VHIR consolidates its position as an international leader in clinical trials

On International Clinical Trials Day, we take a look at the institution's main data and some of the most important studies.

Activities

Defensa de Tesi 'Utilitat dels factors angiogènics en el retard de creixement intrauterí'

Doctorand: Pablo García Manau, grup de Recerca Medicina maternal i fetal. Vall d'Hebron Institut de Recerca (VHIR) Directors: Dr. Manel Mendoza Cobaleda i Dra. Nerea Maiz Elizaran Tutor: Dr. Antonio Gil Moreno

Activities

Vall d'Hebron Talks by VHIR 'Determinants of tissue perfusion during sepsis resuscitation'

Speaker: Dr Michael R. Pinsky, Professor of Critical Care Medicine (primary), Bioengineering, Cardiovascular Diseases, Clinical & Translational Science, and Anesthesiology at the University of Pittsburgh

News

Air pollution and green spaces influence emotional and behavioural disorders in children

A study led by the Vall d'Hebron Research Institute and the Sant Joan de Déu Research Institute shows that environmental pollution increases the risk of emotional problems, while the presence of green spaces near the school reduces behavioural disorders.

Activities

Vall d'Hebron Talks by VHIR 'Deciphering the IgG Glycome - The 'Sweet' Pathway from Molecular Fundamentals to Translational Research'

Speaker: Dr. Andelo Beletic,  he is a lead researcher at Genos Ltd in Zagreb, a global leader in glycomics, and serves as an Assistant Editor for Biochemia Medica, the official journal of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Abstract: IgG antibodies

News

The Cystic Fibrosis Unit of Vall d'Hebron includes the first patient in a clinical trial with DNA corrective therapy

The team is leading research into new genetic treatments for the disease.

Activities

Career Orientation Day

9:15 h. Arrival 9:30 h. Welcome by Anna Santamaría, Internal Strategy Director at VHIR. 9:45 h. Short talks Amplifying

Activities

Defensa de Tesi 'Molecular insights into ovarian endometriosis: towards a personalized management'

Doctoranda: Carina Masferrer Ferragutcasas, grup de Recerca biomèdica en ginecologia, Vall d'Hebron Institut de Recerca (VHIR) Directors:  Dra. Eva Colás Ortega i Dr. Antonio Gil Moreno Tutora: Dra. Laura Soucek  

News

VHIR is the research centre in Spain that has created the most health spin-offs this century

The report by the Botin Foundation and Inveniam places the Institute only behind the CSIC and the UB.

Activities

II Curs de Farmacogenètica i Farmacogenòmica 'Medicina personalitzada de precisió'

La Medicina Personalitzada de Precisió és un canvi de paradigma en la forma de prestar assistència sanitària que incorpora estratègies de diagnòstic i tractament més eficaces i segures, a més d'aportar solucions per garantir la sostenibilitat dels sistemes sanitaris. Objectius

Activities

Sessions Científiques del Servei de Cardiologia 2024-2025

Formació adreçada a metges especialistes en cardiologia, cirurgia cardiovascular i medicina interna Curs gratuït: No cal inscripció prèvia. Número d'inscripcions: màxim 100. 24 sessions programades Secretaría técnica Milagros Mejia – milagros.mejia@vhir.or

Activities

Jornada Dia Mundial del Lupus

16.30h Benvinguda i presentació

Activities

Vall d'Hebron Talks by VHIR 'ELOVL6 in Pancreatic Cancer: A Key Player in Lipid Metabolism and Chemotherapy Response'

Speaker: Dr. Victor Sánchez - Arévalo Lobo, Principal investigator Molecular Oncology group of the Universidad Francisco de Vitoria-Hospital 12 de Octubre. Madrid. Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a 12% survival rate, highlighting the need for no